Literature DB >> 3160911

A genetic component to the variation of dehydroepiandrosterone sulfate.

J I Rotter, F L Wong, E T Lifrak, L N Parker.   

Abstract

Previous studies have shown wide variation in the normal range of serum concentrations of adrenal androgens, including dehydroepiandrosterone (DHA), and DHA sulfate (DHAS). Much of this variability has been shown to be due to the marked variation of the concentrations of these hormones with age. In a search for other sources of this variation, we examined the distribution of DHAS levels in 178 individuals drawn from 26 families. DHAS was chosen because of its relatively high serum concentration, long half-life, and lack of pulsatile variation. As expected, we observed a large age effect, such that it accounted for 68% of the overall variability. In addition, however, when age was factored out by appropriate polynomial regression, there was a significant genetic component to the residual variation, with a heritability of 65%. Thus there appeared to be a significant genetic determination to DHAS serum levels. The results are in accord with previous studies suggesting a genetic component to the variation in testosterone and sex hormone globulin concentrations, and the known correlation of DHAS and testosterone levels. Thus there appears to be significant genetic control of androgen concentrations in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160911     DOI: 10.1016/0026-0495(85)90023-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

Review 1.  Dehydroepiandrosterone sulfate and longevity: new clues for an old friend.

Authors:  S S Yen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

Review 2.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

3.  Genetic and environmental effects on diurnal dehydroepiandrosterone sulfate concentrations in middle-aged men.

Authors:  Elizabeth C Prom-Wormley; Timothy P York; Kristen C Jacobson; Lindon J Eaves; Sally P Mendoza; Dirk Hellhammer; Nicole Maninger; Seymour Levine; Sonia Lupien; Michael J Lyons; Richard Hauger; Hong Xian; Carol E Franz; William S Kremen
Journal:  Psychoneuroendocrinology       Date:  2011-05-12       Impact factor: 4.905

Review 4.  Sex ratios and hormones in HLA related rheumatic diseases.

Authors:  W H James
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 5.  Genetics of androgen metabolism in women with infertility and hypoandrogenism.

Authors:  Aya Shohat-Tal; Aritro Sen; David H Barad; Vitaly Kushnir; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

6.  Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.

Authors:  Richard S Legro; Allen R Kunselman; Lawrence Demers; Steve C Wang; Rhonda Bentley-Lewis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

7.  Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study.

Authors:  C Berr; S Lafont; B Debuire; J F Dartigues; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 8.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 9.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Serum androgen-anabolic hormones and the risk of rheumatoid arthritis.

Authors:  R Heikkilä; K Aho; M Heliövaara; P Knekt; A Reunanen; A Aromaa; A Leino; T Palosuo
Journal:  Ann Rheum Dis       Date:  1998-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.